Charles Sternberg, Associate Editor10.05.22
Olympus, a leader in designing and delivering medical technology solutions, has unveiled a new patient access program called Olympus UNITE that assists patients in gaining access to new medical technologies.
At this time, the program is supporting patients who are candidates for the Spiration Valve System for the treatment of symptoms caused by severe emphysema and the iTind procedure for the treatment of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).
The program is being administered by PRIA Healthcare Management, an organization with 10 years of experience in helping patients navigate medical insurance systems and access the care of most benefit to them. Patients receive advanced notice of the costs and insurance coverage for the procedure from their healthcare provider, and with this information, they can plan accordingly.
Olympus UNITE may include services such as pre-authorization and patient appeals services, strategic reimbursement support, and hotlines to support coverage, coding, and payment concerns. The Olympus UNITE program is expected to expand to include services for other product areas in the future.
"The Olympus UNITE team works with insurance companies and educates them on the benefits of emerging medical technologies like the Spiration Valve System and the iTind procedure," said Paul Skodny, executive director of Global Health Economics and Market Access at Olympus Corporation of the Americas. "These services help drive efficiencies in the pre-authorization process and may save valuable time for patients, as well as physicians and their staff. Olympus provides pre-service authorization and post-service claims appeal support at no additional cost to our healthcare customers and their patients."
At this time, the program is supporting patients who are candidates for the Spiration Valve System for the treatment of symptoms caused by severe emphysema and the iTind procedure for the treatment of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).
The program is being administered by PRIA Healthcare Management, an organization with 10 years of experience in helping patients navigate medical insurance systems and access the care of most benefit to them. Patients receive advanced notice of the costs and insurance coverage for the procedure from their healthcare provider, and with this information, they can plan accordingly.
Olympus UNITE may include services such as pre-authorization and patient appeals services, strategic reimbursement support, and hotlines to support coverage, coding, and payment concerns. The Olympus UNITE program is expected to expand to include services for other product areas in the future.
"The Olympus UNITE team works with insurance companies and educates them on the benefits of emerging medical technologies like the Spiration Valve System and the iTind procedure," said Paul Skodny, executive director of Global Health Economics and Market Access at Olympus Corporation of the Americas. "These services help drive efficiencies in the pre-authorization process and may save valuable time for patients, as well as physicians and their staff. Olympus provides pre-service authorization and post-service claims appeal support at no additional cost to our healthcare customers and their patients."